Sana Biotechnology, Inc. (SANA)

SEC filing

Sana Biotechnology, Inc.

SANA · CIK 1770121

4 · Aug 27, 2026 · EVP, Chief Scientific Officer PATEL DHAVALKUMAR DHIRAJLAL exercised options for 250K shares; reported 41.16K shares

EVP, Chief Scientific Officer PATEL DHAVALKUMAR DHIRAJLAL exercised options for 250K shares; reported 41.16K shares

PRIMARY DOCUMENT

xslF345X06/primarydocument.xmlSEC.gov

Graphics and non-inline formats (not embedded below).